★ Sign in to follow
WT

Wilson Therapeutics AB Stock: price and insider trades · Sweden

ISIN SE0008293674SE·

No insider purchase over the last 90 days. The latest, by Andrew Kay, was filed 28 May 2018.

Wilson Therapeutics AB: what insiders have been doing

Wilson Therapeutics AB is a listed company. Its insiders report their share dealings to Finansinspektionen. Wilson Therapeutics AB has had no insider filing for more than a year; the last one goes back to 29 May 2018.

The full history, which starts in 2016, counts 12 purchases against 5 sales.

This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Insider Decl.
18
Thresholds
n/a
Buy Volume
€123M
12 ops. · all time
Sell Volume
€1M
5 ops. · all time
Last declaration on 29 May 2018
Declarations18 total
  • ▼
    Anders Martin-Löf
    Ekonomi/finanschefExecutives
    324,800 SEK45FI-SE
    1,400 shares@ SEK 232.0079.9% of flowISIN SE0008293674FI:csv-85c6bb93962724766ea8
  • ▲
    Andrew Kay
    ChairmanExecutives
    2M SEK27FI-SE
    7,088 shares@ SEK 232.00100.0% of flowISIN SE0008293674FI:csv-051ba1ee57d02670b373
    Canonical exit: 23 Aug 2018 (T+90)
  • ●
    Thomas Plitz
    "CSOExecutives
    0FI-SE
    AvyttringISIN WTX sharesFI:csv-e83306d7e35914d9bfd0
  • ▲
    Genghis Lloyd-Harris
    DirectorExecutives
    21M SEK19FI-SE
    90,000 shares@ SEK 232.0081.9% of flowISIN SE0008293674FI:csv-6d016e6d92c4451335d2
    Canonical exit: 21 Aug 2018 (T+90)
  • ▼
    Carl Bjartmar
    CMOExecutives
    812,000 SEK37FI-SE
    3,500 shares@ SEK 232.0078.6% of flowISIN SE0008293674FI:csv-d9a80cbe4f1d3be25f4a
  • ▼
    Vincent Metzler
    Vice PresidentExecutives
    2M SEK26FI-SE
    10,000 shares@ SEK 232.000.2% of flowISIN SE0008293674FI:csv-fa39f5ac3f5727c9fc31
  • ▼
    Lars Olsson
    VP CMCExecutives
    232,000 SEK31FI-SE
    1,000 shares@ SEK 232.00100.0% of flowISIN SE0008293674FI:csv-284a6298acedc7a3a7dc
  • ▼
    Jonas Hansson
    VDExecutives
    12M SEK30FI-SE
    50,000 shares@ SEK 232.00100.0% of flowISIN SE0008293674FI:csv-1c31db2fdc31c9bc4811
  • ▲
    Anders Martin-Löf
    Ekonomi/finanschefExecutives
    38,850 SEK32FI-SE
    700 shares@ SEK 55.5010.0% of flowISIN SE0008293674FI:csv-8d24f02dd66f18da1618
    Canonical exit: 7 Mar 2017 (T+90)
  • ▲
    Anders Martin-Löf
    Ekonomi/finanschefExecutives
    39,025 SEK32FI-SE
    700 shares@ SEK 55.7510.1% of flowISIN SE0008293674FI:csv-42ca2218e815d114882e
    Canonical exit: 7 Mar 2017 (T+90)
  • ▲
    Lars Olsson
    Vice President of Chemistry, Manufacture and ControlExecutives
    39,938 SEK19FI-SE
    750 shares@ SEK 53.25100.0% of flowISIN SE0008293674FI:csv-e426988c2dd7c139ba17
    Canonical exit: 5 Mar 2017 (T+90)
  • ▲
    Thomas Plitz
    CSOExecutives
    78,316 SEK0FI-SE
    1,500 shares@ SEK 52.2107100.0% of flowISIN SE0008293674FI:csv-4997e4feab6d17cf2535
    Canonical exit: 19 Dec 2016 (T+90)
  • ▲
    Vincent Metzler
    Vice PresidentExecutives
    311,080 SEK26FI-SE
    5,555 shares@ SEK 56.000.0% of flowISIN SE0008293674FI:csv-fa59f359eba841397d4e
    Canonical exit: 5 Dec 2016 (T+90)
  • ▲
    Vincent Metzler
    Vice PresidentExecutives
    248,920 SEK26FI-SE
    4,445 shares@ SEK 56.000.0% of flowISIN SE0008293674FI:csv-d74d34ed445bd54e2192
    Canonical exit: 4 Dec 2016 (T+90)
  • ▲
    Vincent Metzler
    Vice PresidentExecutives
    1B SEK0FI-SE
    4,445 shares@ SEK 257,810.00ISIN SE0008293674FI:csv-1a8c52edbf300f1a4d8c
    Canonical exit: 4 Dec 2016 (T+90)
  • ▲
    Vincent Metzler
    Vice PresidentExecutives
    257,810 SEK0FI-SE
    4,445 shares@ SEK 58.0099.8% of flowISIN SE0008293674FI:csv-e3b8445c9390a01ce9f4
    Canonical exit: 4 Dec 2016 (T+90)
  • ▲
    Carl Bjartmar
    CMOExecutives
    206,675 SEK25FI-SE
    3,500 shares@ SEK 59.0521.4% of flowISIN SE0008293674FI:csv-c1b1334578498d901e74
    Canonical exit: 1 Dec 2016 (T+90)
  • ▲
    Genghis Lloyd-Harris
    DirectorExecutives
    4M SEK13FI-SE
    90,000 shares@ SEK 47.5018.1% of flowISIN SE0008293674FI:csv-a03cf4663f14f9a5bc01
    Canonical exit: 16 Nov 2016 (T+90)

18 of 18 declarations

About Wilson Therapeutics AB

Wilson Therapeutics AB is a biopharmaceutical company focused on developing treatments for hereditary copper disorders. It is listed on the Stockholm Stock Exchange.

Related companies and executives

No related entities found.